EGFR and breast cancer: To underline the importance of HER2 over HER1 signalling in relation to a detectable SP in BC cells, we also used the selective HER1 (ErbB1, EGFR) inhibitor AG1478, which has a 100-fold higher specificity for HER1 than HER2 (Egeblad et al, 2001).